Currently in shortage
Global demand exceeding manufacturing capacity. Significant increase in prescribing for both type 2 diabetes and weight management.
Expected resolution: 30 June 2026
semaglutide
Ozempic
1 mg/dose · injection · GLP-1 Agonists
PBS Pricing
| General patient co-payment | $31.60 |
| Concession co-payment | $7.70 |
| Full dispensed price | $149.00 |
PBS Information
- Item code
- 3333C
- Drug name
- semaglutide
- Brand name
- Ozempic
- Manufacturer
- Novo Nordisk
- Formulation
- injection
- Strength
- 1 mg/dose
- Max quantity
- 4 units
- Max repeats
- 5
- PBS listed
- Yes
- Therapeutic group
- GLP-1 Agonists
TGA Reference: TGA-MSI-2024-001 · Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.